NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 208 filers reported holding NEKTAR THERAPEUTICS in Q3 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,171,000 | +3398.0% | 530,800 | +4556.1% | 0.17% | +2716.7% |
| Q3 2021 | $205,000 | +10.8% | 11,400 | +4.7% | 0.01% | -14.3% |
| Q4 2020 | $185,000 | -76.5% | 10,892 | -70.2% | 0.01% | -89.9% |
| Q4 2019 | $788,000 | +203.1% | 36,528 | +156.1% | 0.07% | +187.5% |
| Q3 2019 | $260,000 | -38.8% | 14,264 | +19.4% | 0.02% | -38.5% |
| Q2 2019 | $425,000 | -49.0% | 11,944 | -72.0% | 0.04% | -77.5% |
| Q2 2017 | $833,000 | – | 42,600 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |